178 related articles for article (PubMed ID: 8604281)
21. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
[TBL] [Abstract][Full Text] [Related]
22. Statement on meningococcal vaccination for travellers. Committee to Advise on Tropical Medicine and Travel.
CMAJ; 1995 Aug; 153(3):303-8. PubMed ID: 7614446
[No Abstract] [Full Text] [Related]
23. Neisseria meningitidis: presentation, treatment, and prevention.
Ferguson LE; Hormann MD; Parks DK; Yetman RJ
J Pediatr Health Care; 2002; 16(3):119-24. PubMed ID: 12015670
[TBL] [Abstract][Full Text] [Related]
24. [Only a directed prevention against meningococcal disease is justified. Inform patient's contacts about the risk of infection instead].
Carlsson M; Franzén L; Fredriksson M; Persson O; Wärme A
Lakartidningen; 2000 Sep; 97(37):3982-4. PubMed ID: 11036355
[No Abstract] [Full Text] [Related]
25. Clinical and epidemiological implications of meningococcal disease.
Meredith ; Galwankar S
J Assoc Physicians India; 2005 Jul; 53():628-33. PubMed ID: 16190134
[TBL] [Abstract][Full Text] [Related]
26. Meningococcal vaccines: a neglected topic in travel medicine?
Wilder-Smith A
Expert Rev Vaccines; 2009 Oct; 8(10):1343-50. PubMed ID: 19803757
[TBL] [Abstract][Full Text] [Related]
27. [Haemophilus influenzae type b invasive disease and meningococcal disease: incidence and characteristics in Barcelona, 1994-1995. Work Group IMS-IUSPC for Surveillance and Control of Meningitis].
Beni C; Caylà JA; Jansà JM; Maldonado R; Pañella H; Rajmil L; Villalbí JR
Med Clin (Barc); 1999 Jan; 112(1):1-4. PubMed ID: 10027177
[TBL] [Abstract][Full Text] [Related]
28. Meningococcal disease.
Memish ZA; Alrajhi AA
Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
[TBL] [Abstract][Full Text] [Related]
29. Meningococcal disease.
Daley AJ
Aust Fam Physician; 2003 Aug; 32(8):597-601, 603-5. PubMed ID: 12973866
[TBL] [Abstract][Full Text] [Related]
30. Meningococcal disease: was Ottawa's mass-vaccination program necessary?
Gray C
CMAJ; 1992 Mar; 146(6):1033, 1036-7. PubMed ID: 1544060
[No Abstract] [Full Text] [Related]
31. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
[TBL] [Abstract][Full Text] [Related]
33. Meningococcus: a menace in Cork?
Ryan FM; Foley-Nolan C; Keane E; O'Sullivan M; Clair J; Cryan B; O'Murchu E
Ir Med J; 1996; 89(1):21-2. PubMed ID: 8984076
[TBL] [Abstract][Full Text] [Related]
34. Completeness and timeliness of reporting of meningococcal disease--Maine, 2001-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(7):169-72. PubMed ID: 19247263
[TBL] [Abstract][Full Text] [Related]
35. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
National Advisory Committee on Immunization (NACI)
Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
[No Abstract] [Full Text] [Related]
36. The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease.
Harrison LH; Pelton SI; Wilder-Smith A; Holst J; Safadi MA; Vazquez JA; Taha MK; LaForce FM; von Gottberg A; Borrow R; Plotkin SA
Vaccine; 2011 Apr; 29(18):3363-71. PubMed ID: 21376800
[TBL] [Abstract][Full Text] [Related]
37. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
[No Abstract] [Full Text] [Related]
38. The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.
Holst J; Feiring B; Naess LM; Norheim G; Kristiansen P; Høiby EA; Bryn K; Oster P; Costantino P; Taha MK; Alonso JM; Caugant DA; Wedege E; Aaberge IS; Rappuoli R; Rosenqvist E
Vaccine; 2005 Mar; 23(17-18):2202-5. PubMed ID: 15755595
[TBL] [Abstract][Full Text] [Related]
39. [Policy for the prevention of meningococcal infections in Belgium].
De Wals P
Rev Epidemiol Sante Publique; 1983; 31(3):273-82. PubMed ID: 6658101
[TBL] [Abstract][Full Text] [Related]
40. Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners.
Marks PJ; Neal KR
BMC Public Health; 2001; 1():16. PubMed ID: 11806758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
